Source: MarketScreener

ObsEva: Geneva Court Grants Temporary Moratorium to ObsEva

(marketscreener.com) Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland - 31 January 2024 - ObsEva SA , a biopharmaceutical company developing novel therapies for women's health, today announced that it was granted a temporary moratorium by the competent court in Geneva, Switzerland. The...https://www.marketscreener.com/quote/stock/OBSEVA-153872618/news/Geneva-Court-Grants-Temporary-Moratorium-to-ObsEva-45846291/?utm_medium=RSS&utm_content=20240131

Read full article »
Annual Revenue
$5.0-25M
Employees
1-25
Fabien de Ladonchamps's photo - CEO of ObsEva

CEO

Fabien de Ladonchamps

CEO Approval Rating

82/100

Read more